PARP2 and breast neoplasm: Indeed, we have observed a reduction in tumor growth in PARP-1-deficient host-mice and in PARP-2-deficient host-mice, compared to wild-type specimens, in both a C57 syngeneic tumor model induced by the AT-3 breast tumor cell line [23] and in a Balb/c syngeneic tumor model induced by the LP07 lung adenocarcinoma cell line [76], in which both cancer cells lines are proficient for PARP-1 and PARP-2 proteins.